Asaph, Inc.

ASAPH

Research and development of pharmaceuticals, therapeutics, and biologics for the treatment of viral infection, bacterial infection, fungal infection, and parasitic infestation; Research and development of biosynthetic pathways involved in response to viral infection, bacterial infection, fungal infection, and parasitic infestation; Research and development of biosynthetic pathways and their evolution in response to viral infection, bacterial infection, fungal infection, and parasitic infestation; Research and development in the field of bioinformatics-derived drug discovery; Research and development of software-based platforms for the identification of novel therapeutic drug compounds, namely, software-based platforms for collecting, identifying, and searching collections of natural products and/or biosynthesis pathways and generating a drug compound database that allows for structure guided searching to identify new therapeutic drug candidates; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics;